STEPHANIE WINTER: Open Payments
NPI 1235326620 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 6 payments from 6 companies in 2025. Trend: 2023 $16 · 2024 $312 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $141 |
| Vanda Pharmaceuticals Inc. | 1 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $14 |
Products named: COBENFY, FANAPT, INVEGA SUSTENNA, ABILIFY ASIMTUFII, Jornay PM, Dyanavel XR.
Industry payments across AZ — which companies pay providers there.
